Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced the publication and discussion of a ...
Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing differentiated molecules addressing serious liver diseases, announced positive results from a phase 2 study evaluating the ...
Eating a balanced diet and engaging in regular exercise are crucial for maintaining a healthy weight because fatty liver disease and obesity are major risk factors for cirrhosis. Controlling diseases ...